Current status of canine urolithiasis.
D000284:Administration, Oral; D000367:Age Factors; D000493:Allopurinol / Q000008:administration & dosage; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000008:administration & dosage; D003553:Cystine / Q000032:analysis / Q000378:metabolism; D004035:Diet Therapy; D004283:Dog Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control / Q000601:surgery; D004285:Dogs; D005260:Female; D006863:Hydrogen-Ion Concentration; D008297:Male; D010070:Oxalates / Q000032:analysis; D010710:Phosphates / Q000032:analysis / Q000378:metabolism; D011183:Postoperative Complications / Q000517:prevention & control; D012737:Sex Factors; D014527:Uric Acid / Q000032:analysis / Q000378:metabolism; D014545:Urinary Calculi / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control / Q000601:surgery / Q000662:veterinary*; D014552:Urinary Tract Infections / Q000517:prevention & control / Q000662:veterinary
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D010070:Oxalates; D010710:Phosphates; D014527:Uric Acid; D003553:Cystine; D000493:Allopurinol